comparemela.com

Latest Breaking News On - Nephrology at stanford university - Page 1 : comparemela.com

Vera Therapeutics to Host In-Person R&D Day in New York to Present Week 72 Data from Phase

BRISBANE, Calif., Jan. 08, 2024 (GLOBE NEWSWIRE) Vera Therapeutics, Inc. (Nasdaq: VERA), a late clinical-stage biotechnology company developing and commercializing transformative treatments for patients with serious immunologic diseases, today

United kingdomLong island jewish medical centerNew yorkUnited statesJonathan barrattJoyce allaireRichard lafayetteMari purpuraStanford university department of medicineNephrology at stanford universityCommunications committeeStanford glomerular disease centerRenal research groupGlomerular disease advisory committeeAmerican society of nephrologyLotte new york palace hotel

Vera Therapeutics to Host Presentation of Week 36 Data from Phase 2b ORIGIN Clinical Trial of Atacicept in IgAN

BRISBANE, Calif., June 15, 2023 Vera Therapeutics, Inc. , a late-stage biotechnology company focused on developing and commercializing transformative treatments for patients with serious. | June 15, 2023

United statesJoyce allaireRichard lafayetteAmerican society of nephrologyNephrology at stanford universityVera therapeutics incEuropean renal associationLong island jewish medical centerYork medical collegeStanford glomerular disease centerCommunications committeeCongress onF acp stanford university medical centerStanford university school of medicineCastle connolly medical ltdStanford university department of medicine

vimarsana © 2020. All Rights Reserved.